BA.2.86: The next Serotype

By now we can be quite sure that BA.2.86, the new highly mutated version of SARS2, will cause another big global wave of infections. It has been spotted in at least eight countries by now and looks basically identical in all of them, which means it has already rapidly started spreading. If it was bad at spreading itself and nobody had simply noticed it, you would expect to see substantial differences between the genomes.

Of the nine sequences uploaded so far, one was a hospitalized patient. And I expect many more to follow, for a number of reasons. To start with, the antibody mismatch simply reduces the protection that people already have built up. The number of Spike mutations is comparable to the Delta -> Omicron shift. In other words, the “wall of antibodies” should now once again be pretty useless.

Second, in contrast to Omicron that probably jumped from rodents back into our species, this version would seem to have evolved in a chronic infection. The chronic infections tend to favor the evolution of increased virulence, because the easiest way to avoid someone’s antibodies for this virus is to spread from cell to cell, prohibiting these antibodies from binding the virus:

Both fusogenicity and tunneling nanotube formation are a form of immune evasion, as they shield viral particles from the impact of nAbs during cell-to-cell spread (152). However, this trait was subsequently lost by the Omicron BA.1 variant (154,155) and its descendants. As properties such as syncytia formation are likely to be under drift, it cannot be ruled out that they will emerge again by chance. Other changes to viral pathogenesis (for example changes in tropism) can be expected to be gained and lost from variant to variant, under conditions of drift. It is important to note that such changes in viral behavior may have a strong impact on virulence,
despite being difficult to anticipate before the fact or predict from in vitro assays.

In BA.2.86 you see such mutations linked to increased fusogenicity. We already know that increased fusogenicity results in higher virulence. It also has the mutation in the Furin cleavage site that seems responsible for Delta’s higher virulence, (681R). Finally, it also has L452W in Spike. L452R is what’s seen in Delta and is part of what helps Delta increase its fusogenicity (and thus virulence) over Omicron. BA.2.86 turns it into Tryptophan, that hasn’t been seen before. But considering it’s a double nucleotide mutation, it’s likely to offer a significant survival advantage somehow.

Most people seem to think Omicron emerged from a chronic infection, but I don’t. If Omicron came from a chronic infection, you would have to wonder why fusogenicity decreased from Delta to Omicron. Fusogenicity allows spreading from cell to cell by merging cells, unaffected by antibodies. Why would a chronic infection lose this ability? This seems illogical to me. BA.2.86 looks far more like a chronic infection: It shows signs of improved fusogenicity compared to its ancestor.

And interestingly enough, we also begin to see some evidence of what van den Bossche has been warning about: A mutation to Threonine right in the Receptor Binding Domain, which enables a sugar molecule to bind that then effectively prohibits antibodies from binding.

What seems to have happened here is that someone became infected, who lacked the capacity to destroy infected cells (no cytotoxic lymphocytes). As a result, the antibodies had to do the job of keeping this virus under control by themselves. So the virus would have hidden in the cells, learning to spread from cell to cell. And in the process it would have changed its Spike so much, that eventually it stumbled upon a version of itself against which the antibodies didn’t even work anymore. And then it could spread from its host to other hosts again. This would explain why only Spike has significantly mutated.

There is however another aspect that needs to be considered. It’s very unusual, for a new variant to emerge that is so different from other variants, but only in its Spike protein. Because the IgG4 antibodies induced by mRNA vaccination are monovalent and don’t induce cross-links on the Spike protein, they are relatively simple to escape through mutation.

It’s really weird to see such a long list of double-nucleotide mutations that enable antibody evasion. It suggests the virus would have been under immense pressure to escape the IgG4 antibodies. The failure of cytotoxic lymphocytes to destroy infected cells may have been caused by the chronic infection itself, as it’s known to reduce CD8+ T cell counts and chronic infections cause CD8+ T cell exhaustion.

I want to return to van den Bossche’s prediction for a moment.

What van den Bossche predicts is that variants will eventually emerge, that have glycosylation patterns in the NTD that make the infection enhancing antibodies obsolete. These antibodies pull open the Spike protein and thereby make it easier to infect cells, but they prohibit the virus from becoming attached to dendritic cells. The dendritic cells tend to transport such viral particles to the lower lungs and thus these antibodies have the simultaneous effect of increasing vulnerability to infection, while decreasing the severity of infection. This is argued here.

Does BA.2.86 fit the definition of such a variant, against which these antibodies no longer work? Well returning to the presentation, the NTD supersite, where the antibodies bind, has a whole bunch of antibody escaping mutations. There is even a weird insertion of four amino acids, which tends to be very rare and could have the same effect by obscuring immunogenic regions through structural changes.

It seems likely that these mutations prohibit the polyreactive non-neutralizing antibodies from binding. The immune system would need to develop new antibodies against these regions, but this runs into problems as the new NTD will probably be less immunogenic.

The general pattern I have illustrated for XBB will just continue: Spike will evolve to become less immunogenic. The IgG antibodies our B cells stumble upon through somatic hypermutation that do react with the new BA.2.86 Spike, will be cross-reactive: They will increasingly also bind to self.

The problem you run into with these IgG antibodies that also bind to our own proteins is that they interfere in your body’s own functioning. IgG1 and IgG3 antibodies would cause autoimmune problems, by causing your immune system to attack healthy cells. If you deploy IgG4 antibodies cross-reactive with self, then that is problematic in situations where you do need your immune system to destroy your own cells.

Finally, as a descendant of a persistent infection, you would expect BA.2.86 to be better at establishing persistent infections. This variant appears to be the descendant of an infection that would seem to have continued for over a year.

In a chronic infection, a virus can develop mutations that help it to survive in your body, at the cost of its ability to spread through the air, pass through the mucous membranes and infect another person.

BA.2.86 doesn’t have a lot of new threonine and serine mutations that would enable complete antibody evasion. However, it may be very good at establishing persistent infections, that eventually lead to such mutations that cover the Spike protein in sugar molecules and make the antibodies powerless.

However, as I have explained before, there are many different routes we can think of for a virus to survive our neutralizing antibody response. Glycosylation is just one route to worry about. With BA.2.86 it’s still very early, but we already see evidence of one such route: Improved fusogenicity. This is likely to result in higher intrinsic virulence than other Omicron variants.

The bigger problem I think we’re faced with is as following: There’s ultimately nothing that requires a new variant to force the dominant variant into extinction. Variants that are sufficiently different can just co-exist. And then over time, they can adjust themselves, to make use of the immunological conditions produced by the other variant, as observed for Dengue. This is the serotype scenario I have mentioned before. Have a look at Australia:

This is XBC.1.6* In Australia, a Delta-BA.2 hybrid. You can see it’s just not being forced into extinction by the variants that are dominant elsewhere.

Here you can see the Spike mutations. XBC.1.6 has 14 mutations EG.5.1 doesn’t have, EG.5.1 has 17 (the XBB family as a whole has 15) that XBC.1.6 doesn’t have. They’re different enough that neither is able to wipe the other out in Australia. Instead they exist side by side, which suggests they’ll now evolve to stop interfering with each other.

This is different from when Omicron first emerged. Omicron was so good at spreading itself, that it practically wiped out Delta. Delta got no real chance to adopt, except in the failed zero COVID utopia Australia, where it gave birth to XBC.1.6.

But that seems much less likely to happen now. Instead, it looks like you’re going to have multiple very divergent families circulating together: The XBB family (of which EG.5.1 is part), the BA.2.86 family and the XBC (Delta-Omicron hybrid) family.

None of this really had to happen. It happened because of a number of mistakes. To start with, there are the failed zero COVID utopias, Australia, New Zealand and China. These managed to keep SARS2 out for over a year, until they faced more infectious variants. Then they lost and gave those variants the chance to adapt in a population with very little immunity.

That’s how Australia bred the very fit XBC.1.6 variants. XBC* went extinct in the Philippines, where it first emerged. It’s only in the failed zero COVID utopia Australia, which never had a big Delta wave, where it can train to become a globally co-circulating variant, a separate serotype.

Second, there is the failed vaccine experiment. It looks unlikely that Delta could have survived in a population where everyone had caught Delta. But then a new version of COVID emerged, Omicron, that had changed its Spike protein. And because everyone had been vaccinated against Spike, the Omicron versions could spread themselves very rapidly. By now it is clear that the population has such a strong original antigenic sin effect, that XBB infection doesn’t induce a neutralizing antibody response against XBB. The XBB family can now just continually reinfect people.

It recently became clear that infection by Omicron causes a massively increased risk of reinfection in the short term by a different variant. But until now, the circulating Omicron variants were generally pretty similar.

But now have a look at this:

The two main variants now have a massive 42 mutation difference between them in Spike. This is how you end up with different simultaneously circulating serotypes, where one serotype infects you just as you were busy recovering from the other serotype.

And that’s why we now get even the usual suspects to admit that the vaccine strategy isn’t working. Even Eric Topol now declares that we need a “variant independent vaccine”:

Eric argues that “a variant-chasing strategy doesn’t work”. Well congratulations for figuring that out. It would have been really useful if you could have mentioned this BEFORE YOU ENDORSED INJECTING EVERYONE WITH A VARIANT-CHASING VACCINE.

Because what happened as a result, is that the whole population became stuck with a variant-chasing adaptive immune response, churning out antibodies against the specific part of the virus that mutates most rapidly (Spike). And the population continues deploying basically that same antibody response, even after the virus has radically changed itself. With the birth of XBB*, it has learned how to use the Wuhan-fixated vaccine induced immune response to its own advantage.

A variant-proof immune response is what the body would normally deploy, if we had not tried vaccinating people against Spike. What does that look like?

It means you deploy an affinity maturated IgM antibody response, just like you do for influenza (in the absence of vaccination with inactivated vaccines). IgM is a very big antibody, with multiple branches. This means that it is extremely difficult for the virus to mutate around it. But if your body deploys IgG due to the vaccines, that means IgM never really gets a chance to learn to fight this virus (affinity maturation). Despite not binding as strong at any particular location as IgG, IgM’s massive size compared to IgG makes it very useful when it does bind: It can bend the whole Spike protein out of shape and obstruct access to receptors.

For the IgG we deploy due to vaccination this is much easier, especially with the monovalent IgG4 that people now deploy after mRNA vaccination forced a shift from IgG3 to IgG4. In simple English: The two arms of an IgG4 molecule are identical to each other, meaning that it’s much easier to mutate around than regular IgG antibodies, which in turn are easier to mutate around than IgM antibodies.

Second, it means that you body deploys Natural Killer cells, that take up residence in your tissues where this virus is encountered. These Natural Killer cells have receptors that allow them to recognize whether a cell has been infected by viruses of this nature, because its receptors resemble the sort of receptors the Spike protein uses to infect cells. The virus can’t really mutate around this. These Natural Killer cells can then either:

  1. Kill the infected cells.
  2. Release Interferon Gamma, a molecule that helps the cell get rid of any viral material infecting it.

There are various other elements of the innate immune response too. Susceptible cells get better over time at learning to recognize viral threats. Even your infected tissues themselves get better at coping with infection, through vascular and lymphatic remodeling.

This is what a “variant-proof” strategy looks like.

And these morons should have known this.

If you’re sitting there in August 2023, watching as three families circulate simultaneously, unaffected by the immunity induced by their distant cousins, utilizing the original fixation against Wuhan to their own advantage and declare that “well guys, I think we need a variant-independent vaccine”, you’re a moron. It means you’re incompetent, or worse, dishonest.

“We need a variant-independent vaccine” is not some sort of clever insight. It’s like looking at the energy crisis in Europe today and saying “we need some sort of mysterious glowing blue box that generates cheap and abundant energy”. A clever insight would have been to warn about the risk of depending on Russian energy, before we signed up for it.

They should have figured this out in 2020. That’s their job. Their job is to use their insight, their knowledge, to warn the politicians and the general public against the risk of easy technofixes that may appear to work at first but make everything much worse in the long run. But that job ended up falling in the lap of anonymous dudes with obscure blogs.

27 Comments

    • Maybe.

      I still think it’s more likely that people just panicked and went for opportunistic short-term solutions.

      “There’s a new virus killing people, let’s keep it out of our country” is a simple idea.

      “If we keep a new virus out of our country but eventually fail to keep it out, we will be a breeding ground for new versions to emerge that can infect the rest of the world again” is a more difficult idea.

      If something sounds sensible to stupid cowardly opportunistic people, then that’s likely what happened.

      The problem is that you’re engaged in a conflict, with an opponent who adjusts to your moves.

      Within that context, simple ideas become dangerous mistakes.

      • It’s both. The occult intergenerational elite have many factions, plans and contingencies; that which occurs follows the path of least resistance.

        All the world’s a stage, but the audience are the primary actors. Good luck staring past the floodlights to spot the stagehands.

        Course sometimes it’s obvious, like a wig falls off. Pay no attention to my unfortunate hair loss, human. Have a dime while I adjust your atmosphere.

        https://schedule.wttw.com/series/19630/John-D-Rockefeller-American-Experience/

        Kind of amusing that a lizard-looking motherfucker is responsible for CO2 emissions, but wouldn’t it be funnier if an android-looking motherfucker was responsible for the digital hivemind? We live in a society.

        ODDKO – Disobey (Official Music Video)
        https://www.youtube.com/watch?v=Bbs1jxL_lQA

  1. Thank you very much for posting another interesting yet worrying update. Dr. Vanden Bossche also recently released a thoroughly detailed 58 page PDF report on the link between IgG4, excess deaths, “turbo cancers” and autoimmune diseases. It certainly makes for sobering reading. Unfortunately Dr. Vanden Bossche expects these disease rates to accelerate for the foreseeable future. As if the “inescapable immune escape pandemic” wasn’t bad enough on its own. However, it seems that based on Vanden Bossche’s predictions, these VBTI (vaccine breakthrough infections) and IgG4 related excess deaths that we are currently seeing will pale in comparison to the final ending of this pandemic. Here is a chilling passage from his paper that will keep you up at night:

    “The stronger the immune protection, the greater the potential
    infectiousness of newly emerging immune escape variants, leading to a
    higher incidence rate of VBTIs and, consequently, an increased rate of viral
    transmission. Although a high viral transmission rate ensures adequate
    training of the innate immune system in the unvaccinated, it prevents
    a highly C-19 vaccinated population from developing herd immunity!
    Nevertheless, herd immunity is the only mechanism that can ensure
    survival – and therefore long-lived protection – of a human population
    against acute self-limiting infections.

    Nature will establish herd immunity for the benefit of the host species’ survival. In order to achieve this, it will preserve individuals capable of
    making effective contributions to it while relinquishing those who are
    unable to do so (i.e., due to inadequate, deficient, or weakened innate
    immunity).

    Thus, it is not surprising that once the innate immunity of the
    unvaccinated has been trained strongly enough to possess sterilizing
    capacity against highly infectious circulating variants, the strong
    protection from C-19 disease in vaccinated individuals will suddenly
    transition to a heightened susceptibility to enhanced severe C-19 disease.

    To build efficient herd immunity during a natural pandemic, it suffices
    when the vast majority of the population acquires natural immunity. However, in the case of an immune escape pandemic (i.e., in a highly C-19 vaccinated population) that remains untreated, the portion of the
    population that is unable to sterilize the steadily emerging immune escape
    variants will inevitably succumb to the disease. This will automatically
    diminish viral transmission to a level where the virus can no longer
    survive, thus strengthening herd immunity (in the remainder of the
    population) beyond a threshold that would allow the virus to become
    endemic in the human population.

    This implies that it is the host species, not the virus, that will ultimately
    triumph!

    Based on the above, it can already be inferred that the human cost in lives
    during an immune escape pandemic is significantly greater than during a
    natural pandemic, where the selective loss of lives aids in preserving the
    overall population’s health. While herd immunity serves as the solution
    to end both a natural pandemic and an immune escape pandemic, the
    processes of its establishment and the resulting outcomes differ. In the
    context of a natural pandemic, it will lead the virus into endemicity,
    while in the case of an immune escape pandemic, it will lead to virus
    eradication.”

    Here is a link to the article which contains a further link to download the full PDF:

    https://www.anhinternational.org/news/c19-jabs-as-drivers-of-turbo-cancers-and-autoimmune-flare-ups/

    • Apologies for the formatting errors in my above comment that makes it difficult to read (at least on mobile devices). It can be quite tricky when copying and pasting on my phone. It may be easier to read it directly from the report (pages 48-49 of the PDF).

      • Yeah, it seems plausible.

        Personally, I’m more convinced we’re faced with an imminent serotype scenario however.

        The reason is because we can clearly see that going on in Australia right now. XBC* stays hovering around 30%. The longer that continues, the more likely it is they’re finding separate niches.

        If it actually manages to stop infections, the new booster would just make it worse: It will be better at stopping XBB* than XBC* or BA.2.86. Any attempt at vaccinating against the dominant variant means encouraging serotype formation.

        You can see here that IgM/IgG ratios are completely screwed up in breakthrough infections:

        https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509181/

        IgM would be expected to be much better at dealing with multiple circulating serotypes than IgG(4).

        We have never done something this stupid with the hCovs, so I wouldn’t expect this to end up like another hCov anytime soon.

        If someone showed me billions of people have an IgG4 dominant antibody response against the hCovs I would also shit myself.

      • I’m pretty sure Bossche has said the people who are best off are those who have been infected (with Omicron) but of course, not been vaxxed. (Or was it you who said this?)
        You seem to disagree because “it has recently became clear that infection by Omicron causes a massively increased risk of reinfection in the short term by a different variant.”
        Thanks for another fascinating covid essay.

    • Thanks for posting this, I had seen the webpage but not realized it was a 50 page manuscript again.

  2. Great post. I agree with many things you said.

    There is a chance that BA.2.86 will NOT be the “next big thing”. It is possible that it is a random outcome of a small local superspreader event, like a gay sauna party or whatever, that was spread across several countries.

    If I recall correctly, Netherlands still does a decent job sequencing, and they are finding more BA.2.86 sequences, but nothing dramatic to indicate rapid local growth.

  3. There’s no real way to say one way or another, but my intuition tells me that the world (especially America) is quickly approaching a boiling point. Seems like some great chaos is just over the horizon. Godspeed, fellow autists.

  4. Notice what that MF Topol says:
    “will be problematic and epitomizes why a variant-chasing strategy doesn’t work. We need a variant-proof vaccine, and *many* candidates exist.”
    i.e., we really fucked up the first time but don’t worry we’ve got “candidates” that will unfuck all of this — trust us.
    The only successfully field-tested vaccine I’m aware of that *might* be safe&effective is Covax-19, which those other MFs in the Australian pharmaceutical-academic-government complex are fighting tooth-n-nail to bury and to cancel the inventor, Prof. Petrovsky.
    https://open.spotify.com/episode/4vFs25vM5Mlx7QXrcSVrGm
    https://vaxine.net/projects/

  5. Where is the doom porn?

    Whenever you write about climate we get cool apocalypse stuff, like heat, smoke and Satan. But where are your apocalyptic visions of covid?

    • >But where are your apocalyptic visions of covid?

      Separate serotypes with Delta level intrinsic virulence is not apocalyptic enough for you?

      Try getting infected four times a year with such serotypes and see what happens.

    • The biggest question is whether people ever clear this. If you have forever (well, until death) reservoirs, like with AIDS, then the Daniel Dugger scenario unfolds, and nearly everyone dies within ten years (since their white blood cells decline and their livers and kidneys are too badly shot for them to take antivirals, and besides of course there wouldn’t be enough antivirals in a world of dying people). If people can clear it then there is some hope of avoiding future infection and repairing damage. Do you need to have multiple infections to have this problem with clearing it? Or is one infection enough? It doesn’t really matter that people get infected over and over if they are toast anyway if they can’t clear even one infection.

  6. >there are many different routes we can think of for a virus to survive our neutralizing antibody response.

    And, of course, many more which we cannot even conceive of because there are aspects of biology which we simply have no understanding of yet. Unknown unknowns as it were.

    > It happened because of a number of mistakes.

    I think that describing any of this as a “mistake” is an error. Certainly the route may be blunderous, but the destination of massive worldwide suffering seems to be the goal of these demons.

  7. I know you have suggested nattokinase in the past, I am taking it.

    Any idea on whether Ivermectin would still work against these new variants? Thank you.

    • If constant reexposure/infection is the future, should we treat it? It seems the vaxxinated immune damaged probably would not benefit long term with treatment, but what about the unvaxxed? Early treatment could give an intact immune system time to respond…..And what TX? IVM,HCQ,Zn,etc???

    • I think if Ivermectin was the sort of miracle solution online LSWMs think it is, some country would be using it by now.

      It’s kind of hard to keep such a thing covered up.

      We would be hearing that in Cuba or Iran or Switzerland, or Saudi Arabia or heaven knows where it’s now a standard part of the treatment protocol in hospitals.

      The fact that we’re not hearing anything like that, suggests to me it doesn’t work.

      • Or more cynically pharma can’t make enough profits from a five cent pill to keep the directors and shareholders happy. It needs a patented drug which costs $500 or preferably $5,000 per course of treatment. Trebles all round.

        Other drugs that are out of patent but still seem pretty effective include metformin, HCQ & aspirin. One advantage of drugs having been around for 40 or 60 years is that their safety is better understood. Read Peter Gotzsche’s book ‘Deadly Medicines and Organised Crime’ (2013) on what happens with more modern ones. The side-effects may be worse than their predecessors … but this information is suppressed, because it would threaten sales.

  8. There is now a surge of cases of viral myositis in Mumbai. It is “characterized by high fever and severe muscle inflammation;” “patients are reporting muscle aches, weakness and restlessness.” And fainting. Ordinarily, since these patients have a low WBC count and low platelet counts, they would assume it was dengue or malaria, but their symptoms don’t align with dengue and malaria symptoms. (Mumbai Mid-Day, 28 August 2023)

    mrmickme on twitter is saying that there is reason to think that although the RAT tests are still working (more or less), the primers for the PCR tests and wastewater tests are no longer working for some of the new variants.

  9. Im not sure if you have seen this already, (sry if thats the case)
    but there was a study on how the fusogenicity can cause neurons to blob together.
    Spike needs hACE2, but with that present it causes blobs.
    These blobs also generally keep “firing” and only 10% get deactivated.
    The Vax spike(s2) does not show this according to them.
    Not that that is a big help when the vax causes you to get infected every 2 weeks.

    https://www.science.org/doi/10.1126/sciadv.adg2248

    “Our results indicate that viral infections, driving the expression of viral fusogens, can initiate the irreversible fusion of brain cells, causing alteration in neuronal communication and revealing a possible pathomechanism of neuronal malfunction caused by infection. The impact on neuronal fusion will depend on the viral load in the brain and the specific areas infected; for example, in the case of SARS-CoV-2, neuronal fusion depends on the expression of hACE2 and, potentially, other accessory entry factors such as TMPRSS2 and NRP1 in neighboring neurons.”

Leave a Reply

The patients in the mental ward have had their daily dose of xanax and calmed down it seems, so most of your comments should be automatically posted again. Try not to annoy me with your low IQ low status white male theories about the Nazi gas chambers being fake or CO2 being harmless plant food and we can all get along. Have fun!

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.